{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-060704","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.141362+00:00","generated_at":"2026-05-19T02:39:24.343751+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"SELLAS annual meeting results: directors re-elected, ESPP amendment approved","bullets":["Re-elected Class III directors Stergiou (36.4M for) and Varian (36.7M for); broker non-votes 17.8M.","Ratified Baker Tilly as auditor for FY2025: 56.9M for, 3.4M against, 1.0M abstain.","Approved ESPP amendment increasing shares by 800,000: 28.8M for, 14.0M against.","Non-binding advisory vote on executive compensation passed: 29.6M for, 12.8M against.","Recommended annual frequency for future say-on-pay votes (34.8M for 1 year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-060704","json":"https://secwatch.observer/filing/0001104659-25-060704.json","markdown":"https://secwatch.observer/filing/0001104659-25-060704.md","text":"https://secwatch.observer/filing/0001104659-25-060704.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925060704/0001104659-25-060704-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925060704/tm2518346d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:39:24.343751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}